4D Molecular Therapeutics, Inc. (FDMT) Net margin 2019–2025
4D Molecular Therapeutics, Inc. (FDMT) net profit margin by fiscal year — reported net income divided by reported revenue.
-164.4%FY2025 · since FY2019: -708.4% → -164.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -164.4% | +434613.9 pp |
| FY2024 | -434778.4% | -434291.8 pp |
| FY2023 | -486.6% | +2948.8 pp |
| FY2022 | -3435.4% | -3040.0 pp |
| FY2021 | -395.4% | +28.9 pp |
| FY2020 | -424.3% | +284.2 pp |
| FY2019 | -708.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice